Sign in
4

Changes in Ownership

Monte Rosa Therapeutics, Inc. Filed Acc 0000950170-25-002102

Chief Medical Officer acquired 36,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Janku Filip Chief Medical Officer 2025-01-02 Grant or award +36,000 45,189 D
Derivatives
Janku Filip Chief Medical Officer 2025-01-02 Grant or award · Stock Option (Right to Buy) +161,000 161,000 D
Loading xslF345X05/ownership.xml…